Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent ...

In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...

A recent study found that 11 percent of women experience an adverse effect from mifepristone, 22 times higher than its ...

The following is the transcript of an interview with FDA commissioner Dr. Marty Makary that aired on "Face the Nation with ...

Dr. Marty Makary, the Johns Hopkins surgeon and professor whom President Donald Trump tapped to lead the U.S. Food and Drug ...

Health and Human Services Secretary Robert F. Kennedy Jr. has asked Food and Drug Administration Commissioner Marty Makary ...

The Food and Drug Administration will conduct a review of the abortion pill mifepristone following intense pressure from Sen.

Dr. Marty Makary, head of the U.S. Food and Drug Administration (FDA), said Wednesday that the decision should be made between a pregnant woman and her doctor. “The data on the COVID vaccine booster ...

FDA Commissioner Marty Makary said he is “committed” to conducting the review in a June 2 letter addressed to Missouri Sen.

FDA Commissioner Marty Makary hinted on Sunday at shifting the U.S. healthcare system away from standard treatment to a more ...

The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...